Cancer Cells Aren’t Purposefully Wasting Glucose, They’re Consuming It Too Quickly A new study by researchers at Washington University in St. Louis School of Medicine has shed light on why cancer cells consume excessive amounts of glucose, but do not always metabolize it efficiently. The research is published in Molecular
Israeli Scientists Develop AI to Treat Cancer An artificial-intelligence algorithm to identify a group of “point mutations” that cause cancer in TP53 – a gene involved in about half of all cancerous tumors – has been developed for the first time in the world by a group of researchers at
Scientists Develop 'Off the Shelf' Engineered Stem Cells to Treat Aggressive Brain Cancer Glioblastomas (GBMs) are highly aggressive cancerous tumors of the brain and spinal cord. Brain cancers like GBM are challenging to treat because many cancer therapeutics cannot pass through the blood-brain barrier, and more than 90 percent of
Nanoparticles Are the Future of Medicine – Researchers Are Experimenting With New Ways to Design Tiny Particle Treatments for Cancer When you hear the word “nanomedicine,” it might call to mind scenarios like those in the 1966 movie “Fantastic Voyage.” The film portrays a medical team shrunken down to ride
Novel Treatment Makes Pancreatic Cancer Susceptible to Immunotherapy, Mouse Study Shows Pancreatic cancer is one of the most aggressive and deadly tumor types and notorious for its resistance to virtually all types of treatment, including newer immunotherapies. Read more...
FDA Approves Second CAR-T Cancer Therapy to Treat Multiple Myeloma, Opening the Door for Greater Access The Food and Drug Administration on Monday approved a new CAR-T therapy for multiple myeloma, a move that could ease strain on limited supplies of potentially lifesaving cancer therapies. Read more...
Researchers Label Early CAR-T Therapy Patient ‘Cured’ After Living a Decade Without Cancer In 2010, Doug Olson became the second person in the world to receive CAR-T cell therapy, an experimental tactic to engineer his own immune cells to fight cancer. His doctors had tempered expectations for how well it
Biden Relaunches 'Cancer Moonshot' Initiative Aimed at Halving Rate of Cancer Deaths by 2047 President Joe Biden on Wednesday relaunched the White House's "Cancer Moonshot" initiative, committing the nation to working toward reducing the death rate from cancer by at least 50% over the next 25 years. Read more...
New Treatment Target ID’d for Radiation-Resistant Cervical Cancer Understanding how cells die is key to developing new treatments for many diseases, whether the goal is to make cancer cells die or keep healthy cells alive in the face of other illnesses, such as massive infections or strokes. Two new studies
Improving Drug Options for Colorectal Cancer Patients Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim to block the cancer-causing proteins that trigger out-of-control cell growth while sparing healthy tissues. But some patients are not eligible for these treatments because they have cancer-promoting mutations